Hyams JS, Winter HS, Mulberg AE, Zuckerman E, et al. An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel Disease. Inflamm Bowel Dis 2024 Oct 8:izae226. doi: 10.1093.
PMID: 39377256